REFERENCES

Akbas SH, Timur M, & Ozben T. (2005). The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells. Surg Res. 125(1), 49-55.

Bakheet , SA. (2011). Assessment of anti-cytogenotoxic effects of quercetin in animals treated with topotecan. Oxidative Medicine and Cellular Longevity. 2011: ID 824597. doi: 10.1155/2011/824597

Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL Jr, & Brenner DE. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila). 4(3):354-364.

Castillo MH, Perkins, E., Campbell, J.H., Doerr, R., Hassett, J.M., Kandaswami, C., Middleton, E. Jr. (1989). The effects of the bioflavonoid quercetin on squamous cell carcinoma of the head and neck origin. American  Journal of Surgery. 158(4) 351-5.

Du G, Lin H, Wang M, Zhang S, Wu X, Lu L, Ji L, & Yu L. (2010). Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells. Cancer Chemother Pharmacol. 65(2), 277-287.

Du G, Lin H, Yang Y, Zhang S, Wu X, Wang M, Ji L, Lu L, Yu L, Han G. (2010). Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice. Int Immunopharmacol. 10(7), 819-26.

El-Mowafy AM, Salem HA, Al-Gayyar MM, El-Mesery ME, & El-Azab MF. (2011). Evaluation of renal protective effects of the green-tea (EGCG) and red grape resveratrol: role of oxidative stress and inflammatory cytokines. Nat Prod Res. 25(8):850-856.

Ferry DR, Smith, A., Malkhandi, J., Fyfe, D.W., deTakats, P.G., Anderson, D., Baker, J., & Kerr, D.J. (1996). Phase 1 clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clinical Cancer Research. 2(4), 659-68.

Grivennikov S & Karin M. (2010¬). Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer. Cytokine & Growth Factor Reviews, 21(1),  11-19.

Grivennikov SI, Karin M. (2010). Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer. Cytokine & Growth Factor Reviews. 21(10)11-19.

Gugler R, Leschik M, Dengler HJ. (1975). Disposition of quercetin in man after single oral and intravenous doses.  Eur J Clin Pharmacol. 9(2-3),229-234.

Hsu HS, Lin JH, Huang WC, Hsu TW, Su K, Chiou SH, Tsai YT, Hung SC. (2011). Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27. Cancer. 117(7),1516-28. doi: 10.1002/cncr.25599.

Jacquemin G, Granci V, Gallouet AS, Lalaoui N, Morlé A, Iessi E, Morizot A, Garrido C, Guillaudeux T, & Micheau O. Haematologica. (2012). Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells. Haematologica. 97(1),38-46.

Kawahara T, Kawaguchi-Ihara N, Okuhashi Y, Itoh M, Nara N, Tohda. (2009). Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells. Anticancer Res. 29(11), 4629-32.

Kern E, Schmidinger M, Locker GJ, Kopp B. (2007). Management of capecitabine-induced hand-foot syndrome by local phytotherapy. Wien Med Wochenschr. 157(13-14):337-342.

Levy J, Teuerstein, I., Marbach, M., Radian, S., Sharoni, Y. (1986). Tyrosine protein kinase activity in the DMBA- induced rat mammary tumor: inhibition by quercetin. human colon cancer cell lines and in primary colorectal tumors.  Biochemical and Biophysical Research Communications. 134(2), 876-882. Biochem Biophys Res Commun. 1984 Sep 28;123(3):1227-33.

Molnar J, Beladi, I., Domonkos, K., Foldeak, S., Boda, K., Veckenstedt, A. (1981). Antitumor activity of flavonoids on NK/Ly ascites tumor cells. Neoplasma. 28(1),11-8.

Romagnolo DF & Selmin OI. (2012). Flavonoids and cancer prevention. J Nutr Gerontol Geriatr. 31(3):206-238.

Ruiz PA, Braune A, Hölzlwimmer G, Quintanilla-Fend L, Haller D. (2007). Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J Nutr. 137(5), 1208-1215.

Saurabh J. Pradha n, Rosali n Mishra , Pri yanka Sharma and Gopal opal C. Ku ndu. (2010) Quercetin and sulforaphane in combination suppress the progression of melanoma through the down regulation of matrix metalloproteinase-9. National Center for Cell Science, Pune 411 007, India. Received June 26, 2010; Accepted August 16, 2010. DOI: 10.3892/etm.2010.144

Shan BE, Wang MX, & Li RQ. (2009). Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest. 27(6), 604-612.

Shehzad A., Lee J., Huh T.-L., Lee Y.S. (2013). Curcumin induces apoptosis in human colorectal carcinoma (HCT-15) cells by regulating expression of Prp4 and p53. Molecules and Cells. 35(6), 526-532.

Srivastava RK, Tang SN, Zhu W, Meeker D, Shankar S. (2011). Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells. Front Biosci (Elite Ed). 1(3), 515-528.

Staedler D, Idrizi E, Kenzaoui BH, Juillerat-Jeanneret L. (2011). Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells. Cancer Chemother Pharmacol. 68(5), 1161-72.

 Stingl et al. (2011). Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colonadenomas in the elderly population. BMC Cancer.  11:360.

Su-Ni Tang, Chandan Singh, Dara Nall, Daniel Meeker, Sharmila Shankar and Rakesh K Srivastava. (2010). The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.  Journal of Molecular Signaling. 5(14).

Wachter J, Neureiter D, Alinger B, Pichler M, Fuereder J, Oberdanner C, Di Fazio P, Ocker M, Berr F, & Kiesslich T. (2012). Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells. Int J Biol Sci. 8(1), 15-29.

Wardell et al. (2009). Glucose metabolism as a target of histone deacetylase inhibitors.  Molecular Endocrinology. 23(3), 388.

Yallapu MM, Ebeling MC, Khan S, Sundram V, Chauhan N, Gupta BK, Puumala SE, Jaggi M, Chauhan SC. (2013). Novel curcumin loaded magnetic nanoparticles for pancreatic cancer treatment. Mol Cancer Ther. Mol Cancer Ther. 2013 Aug 1. [Epub ahead of print]

Yuan ZP et al. (2006). Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clinical Cancer Research. 12(10), 3193-3199.

Free radicals and antioxidants in normal physiological functions and human disease
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J., Int J Biochem Cell Biol. 2007;39(1):44-84. Epub 2006 Aug 4. Review.PMID: 16978905 [PubMed - indexed for MEDLINE] Related articles

Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M., Chem Biol Interact. 2006 Mar 10;160(1):1-40. Epub 2006 Jan 23. Review.PMID: 16430879 [PubMed - indexed for MEDLINE] Related articles

The redox regulation of thiol dependent signaling pathways in cancer
Giles GI., Curr Pharm Des. 2006;12(34):4427-43. Review.PMID: 17168752 [PubMed - indexed for MEDLINE]

Therapeutic strategies by modulating oxygen stress in cancer and inflammation
Fang J, Seki T, Maeda H., Adv Drug Deliv Rev. 2009 Apr 28;61(4):290-302. Epub 2009 Feb 26. Review.PMID: 19249331 [PubMed - indexed for MEDLINE]Related articles

Reactive oxygen species in tumor progression
Storz P.

Reactive oxygen species and regulation of gene expression
Turpaev KT., Biochemistry (Mosc). 2002 Mar;67(3):281-92. Review.PMID: 11970728 [PubMed - indexed for MEDLINE]

Reactive oxygen species in oncogenic transformation
Behrend L, Henderson G, Zwacka RM., Biochem Soc Trans. 2003 Dec; 31(Pt 6):1441-4. Review.PMID: 14641084 [PubMed - indexed for MEDLINE] Related articles

[The two faces of reactive oxygen species]
Zablocka A, Janusz M.

Modulation of redox signal transduction pathways in the treatment of cancer
Greenberger JS, Kagan VE, Pearce L, Boriseniao G, Tyurina Y, Epperly MW., Antioxid Redox Signal. 2001 Jun;3(3):347-59.PMID: 11491649 [PubMed - indexed for MEDLINE]

Oxidative stress, redox, and the tumor microenvironment
Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB., Semin Radiat Oncol. 2004 Jul;14(3):259-66. Review.PMID: 15254869 [PubMed - indexed for MEDLINE]

Reactive oxygen species: current knowledge and applications in cancer research and therapeutic
Lau AT, Wang Y, Chiu JF., J Cell Biochem. 2008 May 15;104(2):657-67. Review.PMID: 18172854 [PubMed - indexed for MEDLINE] Related articles

Signalling apoptosis: a radical approach
Carmody RJ, Cotter TG., Redox Rep. 2001;6(2):77-90. Review.PMID: 11450987 [PubMed - indexed for MEDLINE] Related articles

Redox signaling of angiogenesis 
Maulik N., Antioxid Redox Signal. 2002 Oct;4(5):805-15. Review.PMID: 12470509 [PubMed - indexed for MEDLINE] Related articles

Role of reactive oxygen species in apoptosis: implications for cancer therapy
Matés JM, Sánchez-Jiménez FM.

The Role of Hypoxia-Induced Factors in Tumor Progression
Institute of Physiology and Pathophysiology, University of Mainz, Mainz, Germany Correspondence: Peter Vaupel, M.D., Dr. Med., M.A., Institute of Physiology and Pathophysiology, University of Mainz, Duesbergweg 6, 55099 Mainz, Germany
ThrombHaemost. 1998 Oct;80(4):598-602.

Pentoxifylline inhibits hypoxia-induced upregulation of tumor cell tissue factor and vascular endothelial growth factor.
Amirkhosravi A, Meyer T, Warnes G, Amaya M, Malik Z, Biggerstaff JP, Siddiqui FA, Sherman P, Francis JL.
SourceCell Biology, Hemostasis and Thrombosis Research Unit, Walt Disney Memorial Cancer Institute at Florida Hospital, Orlando 32804, USA.Ali_Amirkhosravi@mail.fhmis.net
Cancer Sci. 2005 Jul;96(7):394-402. Sasabe E, Tatemoto Y, Li D, Yamamoto T, Osaki T.

Department of Oral Oncology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku-city, Japan.
Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells.
Proc, American Society of Clinical Oncology 21: 2002 (abstr 2806)

Efficacy of pre and post Hyperbaric oxygen as an adjuvant to cis platinum containing regimen, Oxygenation inhibits ovarian tumor growth by down regulating STAT3 and cyclin–D1 expression  Cancer boil Ther, Aug 2010
Selvendiran, Karuppaiyah, Dept of Internal Medicine and Comprehensive Cancer Center, Ohio State Univ. Columbus, OH, USA

Hyperbaric Oxygen Inhibits benign and malignant human mammary epithelial cell proliferation, Granowitz EV, Tonomura N, Benson RM, Dept of Medicine BayState Medical Center, Tuft University School of Medicine, Springfield, MA 01199, USA, UHM 2007, Vol 34, No. 2-HBO2 and lung metastasis

Lung Metastatic loan limitation with hyperbaric oxygen
ABU T.M. PATEL. A.B. Almehdi Department of pharmacology, University of South Alabama College of Medicine, Mobile, AL 36688, World Journal of Surgery, Nov, 2006

Hyperbaric Oxygen Therapy for Malignancy, A review
Jurstine Daruwalla, B. Sc, Chris Christophi, MD, Eur J Cancer. 1996 Jan;32A(1):30-8.

Role of oxygen free radicals in cancer development.
Dreher D, Junod AF., Respiratory Division, Geneva University Hospital, Switzerland., Epub 2010 Sep 17. BiochemBiophys Res Commun. 2010 Oct 15;401(2):262-7.

VEGF secretion during hypoxia depends on free radicals-induced Fyn kinase activity in mast cells.
Sasabe E, Tatemoto Y, Li D, Yamamoto T, Osaki T., Department of Oral Oncology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku-city, Japan., J Biol Chem. 2009 Nov27, 284(48):33185-94. Epub 2009 Oct 1

Reactive oxygen species generating mitochondrial DNA mutation up regulates hypoxia inducible factor-1 alpha gene transcription via phosphatidylinositol 3-kinase-Akt/protein kinase C/ histone deacetylase pathway

Oxygenation inhibits ovarian tumor growth by downregulating STAT3 and cyclin-D1 expressions
MED   10-52   201020562529  NDN- 230-1266-2128-6
AUTHORS- Selvendiran, Karuppaiyah; Kuppusamy, M Lakshmi; Ahmed, Shabnam; Bratasz, Anna; Meenakshisundaram, Guruguhan; Rivera, Brian K; Khan, Mahmood; Kuppusamy, Periannan
   
JOURNAL NAME- Cancer Biol Ther; VOLUME 10; NUMBER 4; PUBLICATION DATE- 2010 Aug PP 386-90    

Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiform, Study Design Primary Purpose: Treatment, Conditions Brain and Central Nervous System Tumors, Intervention hyperbaric oxygen, radiation therapy
National Cancer Institute (NCI) Information obtained from ClinicalTrials.gov on July 15, 2010
 
Efficacy of pre and postirradiation hyperbaric oxygen therapy in the prevention of postextraction osteoradionecrosis: a systematic review
MED   10-52   201020727635  NDN- 230-1264-9854-5 , AUTHORS- Fritz, Gabriel W; Gunsolley, John C; Abubaker, Omar; Laskin, Daniel M, JOURNAL NAME- J Oral Maxillofac Surg, VOLUME 68, NUMBER 11, Nov. 2010, PP 2653-60

Functional and Anatomical Magnetic Resonance Imaging (MRI) of Chronic Brain Injury and Hyperbaric Oxygen (HBO2) Study Subjects: Conditions Brain Injury, Intervention Magnetic Resonance Imaging, Computed Tomography Angiography
Intermountain Health Care, Inc.

Hyperbaric oxygen stimulated proliferation and growth of Osteoblasts may be mediated through the FG-2/MEK/ERK 1/2/NF-B and PKC/JNK pathways
MED   10-52   201020497028  NDN- 230-1272-0128-6, AUTHORS- Hsieh, Cheng-Pu; Chiou, Ya-Ling; Lin, Ching-Yuang   
JOURNAL NAME- Connect Tissue Res, VOLUME 51, NUMBER 6, PUBLICATION DATE-2010 Dec., PP 497-509, DOCUMENT TYPE- Journal Article, JOURNAL CODE- 0365263, JOURNAL SUBSET- MEDJSIM, ISSN- 1607-8438    

Hyperbaric Oxygen Therapy in Treating Patients With Radiation Necrosis of the Brain

Study Design Allocation: Randomized, Control: Active Control, Masking: Single Blind, Primary Purpose: Supportive Care, Conditions Brain and Central Nervous System Tumors, Intervention dexamethasone, hyperbaric oxygen, cognitive assessment, magnetic resonance imaging, positron emission tomography, quality-of-life assessment Status Active, not recruiting, Source National Cancer Institute (NCI)
Information obtained from ClinicalTrials.gov on July 15, 2010

Hyperbaric oxygen therapy reduces amputation risk in chronic wounds
Publish date: Nov 23, 2010, By:  Diane Donofrio Angelucci, Source: Dermatology Time

Innovation and Management of Diabetic Foot Wounds.

Clemens MW, Broyles JM, Le PN, Attinger CE., Anderson Cancer Center University of Texas Houston, TX., Surg Technol Int. 2010 Oct;XX:61-71.,  PMID: 21082550 [PubMed - as supplied by publisher

How Can Hyperbaric Oxygen Contribute to Treatment?
J. Scott Delaney, MD; D. L. Montgomery, PhD
THE PHYSICIAN AND SPORTSMEDICINE - VOL 29 - NO. 3 - MARCH 2001

Lung metastatic load limitation with hyperbaric oxygen.
ABU T.M.Y. HAROON, M. PATEL, A.B. AL-MEHDI, Department of Pharmacology, University of South Alabama College of Medicine, Mobile, AL 36688, Sydney M, Evans, Cameron J, Koch, School of Medicine, Dept of Radiation Oncology, University of Pennsylvania, PA 19104, January 2003

Hypoxia and Anemia, factors in decreased sensitivity to radiation therapy and chemotherapy
The Oncologist 2004,9-31, 40, Louis Harrison and Kimberely Blackwell
Hyperbaric oxygen as an adjuvant to cisplatinum containing regimen, a companion to a hard journey, Proc American Society of Clinical Oncology (ASCO) 21: 2002

Hyperoxia increases the uptake of 5- fluorouracil in mammary tumors independently of changes in interstiatial fluid pressure and tumor stroma
Ingris Moen, Carl J Tronstad, Odd Kolmannskog, Dept of Biomedicine, Univ of Bergen, Norway, June 2009